neoplasm
• hypdrodynamic transfection via tail-vein injection of oncogenes myr-AKT and NRasV12 results in barely presented tumor nodules on the liver surface and normal hepatocytes and stromal cells compared to excessive nodular lesions in controls
• mice show increased survival following hypdrodynamic transfection via tail-vein injection of oncogenes myr-AKT and NRasV12 compared to controls
• liver tumor tissues show a reduction in ATP following hypdrodynamic transfection via tail-vein injection of oncogenes myr-AKT and NRasV12
|
homeostasis/metabolism
• primary hepatoma cells from myr-AKT and NRasV12 hypdrodynamic transfected mice show slower growth in hypoxia compared with normoxia ex vivo and slower growth in hypoxia compared to controls
|
cellular
• mice show distorted and atypical mitochondria with vacuoles or abnormal cristae in the hepatocellular carcinoma cells following hypdrodynamic transfection via tail-vein injection of oncogenes myr-AKT and NRasV12; mitochondrial abnormalities are not seen in controls
|
liver/biliary system
N |
• mice show no differences in liver function from controls
|